marginally significantp = 0.053
Age emerged as a significant factor, with individuals aged 26-35 exhibiting a noteworthy increase in the odds of experiencing moderate to severe symptoms of ETD (Exp(B) = 3.899, p = 0.001), while those aged 36-45 showed a marginally significant increase (Exp(B) = 2.626, p = 0.053), in comparison to the reference group (18-25 years).